Medtronic PLC closed 3.70% below its 52-week high of $92.68, which the company achieved on October 24th.
The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...
Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...
Medtronic hired a new chief financial officer away from French carmaker Renault. Thierry Pieton, chief financial officer of ...
Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).
Shares of Medtronic (MDT) traded marginally lower on Thursday after rising from a low of $80.01 from the past six trading sessions, where shares soared overall ...
The final episode of The Leaders’ Room’s season two features Robert O’Brien, country leader of Medtronic Ireland.
Medtronic said the Centers for Medicare & Medicaid Services is opening a coverage analysis on renal denervation for patients with hypertension that will include the review of its medical device. The ...
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Medtronic (MDT – Research Report). The company’s ...
The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and ...